skip to Main Content

The Leading Doctors behind Precision Promise

Newsfeed image, light gray text on dark gray background
Earlier this week we announced Precision Promise, the first large-scale precision medicine trial that will put the patient at the center of every decision and help advance our goal to double pancreatic cancer survival by 2020.

This national effort will transform outcomes for patients with pancreatic cancer and revolutionize the way clinical trials are conducted.

We’re proud to partner with 12 initial medical centers who were selected through a competitive peer-review process. These 12 sites will provide treatment to patients enrolled in the Precision Promise clinical trial come spring 2017. Read more . . .

Back To Top